Publications
-
Treated and untreated kidney failure in older adults: what's the right balance?
Kurella Tamura M,
Winkelmayer WC.
JAMA.
2012;
307
(23):
2545-6
-
Predialysis nephrology care of older patients approaching end-stage renal disease.
Winkelmayer WC,
Liu J, Chertow GM, Tamura MK.
Arch Intern Med.
2011;
171
(15):
1371-8
-
Tackling the Achilles' heel of hemodialysis.
Winkelmayer WC,
N Engl J Med.
2011;
364
(4):
372-4
-
Comparative mortality risk of anemia management practices in incident hemodialysis patients.
Brookhart MA,
Schneeweiss S, Avorn J, Bradbury BD, Liu J, Winkelmayer WC.
JAMA.
2010;
303
(9):
857-64
-
Altitude and all-cause mortality in incident dialysis patients.
Winkelmayer WC,
Liu J, Brookhart MA.
JAMA.
2009;
301
(5):
508-12
-
Determinants of peritoneal dialysis technique failure in incident US patients.
Shen JI,
Mitani AA, Saxena AB, Goldstein BA, Winkelmayer WC.
Perit Dial Int.
2013 Mar-Apr;
33
(2):
155-66
-
Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005).
Yang JY,
Lee TC, Montez-Rath ME, Desai M, Winkelmayer WC.
J Nephrol.
2013 Mar-Apr;
26
(2):
281-8
-
Assessments of causal effects--theoretically sound, practically unattainable, and clinically not so relevant.
Winkelmayer WC,
Heinze G.
Clin J Am Soc Nephrol.
2013;
8
(4):
520-2
-
Commentary on 'The DOPPS Practice Monitor for US dialysis care: trends through December 2011': results from year one.
Weiner DE,
Winkelmayer WC.
Am J Kidney Dis.
2013;
61
(2):
346-8
-
Effect of Conversion From Ciclosporin to Tacrolimus on Endothelial Progenitor Cells in Stable Long-Term Kidney Transplant Recipients.
Riegersperger M,
Plischke M, Steiner S, Seidinger D, Sengoelge G, Winkelmayer WC, Sunder-Plassmann G.
Transplantation.
2013
-
Epidemiologic and statistical methods for comparative effectiveness research.
Hlatky MA,
Winkelmayer WC, Setoguchi S.
Heart Fail Clin.
2013;
9
(1):
29-36
-
Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.
Feldman CH,
Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcón GS, Winkelmayer WC, Costenbader KH.
Arthritis Rheum.
2013;
65
(3):
753-63
-
More evidence on an abominable pairing: atrial fibrillation and kidney disease.
Winkelmayer WC,
Circulation.
2013;
127
(5):
560-2
-
Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study.
Yang JY,
Lee TC, Montez-Rath ME, Chertow GM, Winkelmayer WC.
BMC Nephrol.
2013:
14
97
-
Temporal Trends in the Incidence, Treatment, and Outcomes of Hip Fracture in Older Patients Initiating Dialysis in the United States.
Nair SS,
Mitani AA, Goldstein BA, Chertow GM, Lowenberg DW, Winkelmayer WC.
Clin J Am Soc Nephrol.
2013
-
The Comparative Short-term Effectiveness of Iron Dosing and Formulations in US Hemodialysis Patients.
Kshirsagar AV,
Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Brookhart MA.
Am J Med.
2013;
126
(6):
541.e1-541.e14
-
Trends in Relative Mortality Between Hispanic and Non-Hispanic Whites Initiating Dialysis: A Retrospective Study of the US Renal Data System.
Arce CM,
Goldstein BA, Mitani AA, Winkelmayer WC.
Am J Kidney Dis.
2013
-
Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.
Lenihan CR,
Montez-Rath ME, Mora Mangano CT, Chertow GM, Winkelmayer WC.
Ann Thorac Surg.
2013;
95
(1):
20-8
-
Use and safety of heparin-free maintenance hemodialysis in the USA.
Shen JI,
Mitani AA, Chang TI, Winkelmayer WC.
Nephrol Dial Transplant.
2013
-
Variation in Nephrologist Visits to Patients on Hemodialysis across Dialysis Facilities and Geographic Locations.
Erickson KF,
Tan KB, Winkelmayer WC, Chertow GM, Bhattacharya J.
Clin J Am Soc Nephrol.
2013
-
Predialyis nephrology care of older individuals approaching end-stage renal disease.
Winkelmayer WC,
Kurella Tamura M.
Semin Dial.
2012 Nov-Dec;
25
(6):
628-32
-
Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis.
Winkelmayer WC,
Liu J, Patrick AR, Setoguchi S, Choudhry NK.
J Nephrol.
2012 May-Jun;
25
(3):
341-53
-
Altitude and the risk of cardiovascular events in incident US dialysis patients.
Winkelmayer WC,
Hurley MP, Liu J, Brookhart MA.
Nephrol Dial Transplant.
2012;
27
(6):
2411-7
-
Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?
Shen JI,
Turakhia MP, Winkelmayer WC.
Curr Opin Nephrol Hypertens.
2012;
21
(6):
600-6
-
Causal or casual?-The association between consumption of artificially sweetened carbonated beverages and vascular disease.
Anand S,
Winkelmayer WC.
J Gen Intern Med.
2012;
27
(9):
1100-1
-
Commentary on 'The DOPPS practice monitor for US dialysis care: trends through April 2011': no surprises yet.
Winkelmayer WC,
Weiner DE.
Am J Kidney Dis.
2012;
59
(2):
312-4
-
Commentary on 'The DOPPS practice monitor for US dialysis care: trends through August 2011': an ESA confluence.
Weiner DE,
Winkelmayer WC.
Am J Kidney Dis.
2012;
60
(1):
165-7
-
Comparative effectiveness research: what is it and why do we need it in nephrology?
Chang TI,
Winkelmayer WC.
Nephrol Dial Transplant.
2012;
27
(6):
2156-61
-
Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients.
Fishbane S,
Bolton WK, Winkelmayer WC, Strauss W, Li Z, Pereira BJ.
Clin Nephrol.
2012;
78
(3):
181-8
-
Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States.
Arce CM,
Mitani AA, Goldstein BA, Winkelmayer WC.
Clin J Am Soc Nephrol.
2012;
7
(2):
289-96
-
Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.
Chang TI,
Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA, Winkelmayer WC.
J Am Soc Nephrol.
2012;
23
(12):
2042-9
-
Preoperative statin use and postoperative acute kidney injury.
Brunelli SM,
Waikar SS, Bateman BT, Chang TI, Lii J, Garg AX, Winkelmayer WC, Choudhry NK.
Am J Med.
2012;
125
(12):
1195-1204.e3
-
Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.
Hiraki LT,
Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC, Costenbader KH.
Arthritis Rheum.
2012;
64
(8):
2669-76
-
Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population.
Liem YS,
Wong JB, Winkelmayer WC, Weimar W, Wetzels JF, de Charro FT, Kaandorp GC, Stijnen T, Hunink MG.
Nephrol Dial Transplant.
2012;
27
(1):
429-34
-
Saving the kidneys by sparing intravenous chloride?
Waikar SS,
Winkelmayer WC.
JAMA.
2012;
308
(15):
1583-5
-
The prevalence and cost of unapproved uses of top-selling orphan drugs.
Kesselheim AS,
Myers JA, Solomon DH, Winkelmayer WC, Levin R, Avorn J.
PLoS One.
2012;
7
(2):
e31894
-
Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients.
Yang JY,
Lee TC, Montez-Rath ME, Paik J, Chertow GM, Desai M, Winkelmayer WC.
J Am Soc Nephrol.
2012;
23
(3):
495-506
-
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.
Goldstein BA,
Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC.
Circulation.
2012;
126
(19):
2293-301
-
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis.
Shen JI,
Winkelmayer WC.
Am J Kidney Dis.
2012;
60
(3):
473-86
-
Use of secondary prevention medications among adults with reduced kidney function.
Chang TI,
Gao L, Brown TM, Safford MM, Judd SE, McClellan WM, Limdi NA, Muntner P, Winkelmayer WC.
Clin J Am Soc Nephrol.
2012;
7
(4):
604-11
-
Validation of reported predialysis nephrology care of older patients initiating dialysis.
Kim JP,
Desai M, Chertow GM, Winkelmayer WC.
J Am Soc Nephrol.
2012;
23
(6):
1078-85
-
A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease.
Qunibi W,
Winkelmayer WC, Solomon R, Moustafa M, Kessler P, Ho CH, Greenberg J, Diaz-Buxo JA.
BMC Nephrol.
2011:
12
9
-
Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.
Winkelmayer WC,
J Am Soc Nephrol.
2011;
22
(1):
1-2
-
Air pollution and coronary risk in kidney transplant recipients.
Laden F,
Winkelmayer WC.
Am J Kidney Dis.
2011;
58
(4):
506-7
-
Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors: challenges in comparative effectiveness using Medicare data.
Setoguchi S,
Shrank WH, Liu J, Lee JC, Saya U, Winkelmayer WC, Dreyer NA.
Clin Pharmacol Ther.
2011;
89
(5):
674-82
-
Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.
Chang TI,
Shilane D, Brunelli SM, Cheung AK, Chertow GM, Winkelmayer WC.
Am Heart J.
2011;
162
(2):
324-30
-
Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients.
Winkelmayer WC,
Liu J, Kestenbaum B.
Clin J Am Soc Nephrol.
2011;
6
(1):
175-83
-
Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.
Winkelmayer WC,
Liu J, Setoguchi S, Choudhry NK.
Clin J Am Soc Nephrol.
2011;
6
(11):
2662-8
-
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
Hiraki LT,
Lu B, Alexander SR, Shaykevich T, Alarcón GS, Solomon DH, Winkelmayer WC, Costenbader KH.
Arthritis Rheum.
2011;
63
(7):
1988-97
-
Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.
Winkelmayer WC,
Stedman MR, Pogantsch M, Wieninger P, Bucsics A, Asslaber M, Bauer R, Burkhardt T, Schautzer A, Brookhart MA.
Pharmacoepidemiol Drug Saf.
2011;
20
(1):
57-65
-
Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure.
Haddad F,
Fuh E, Peterson T, Skhiri M, Kudelko KT, De Jesus Perez V, Winkelmayer WC, Doyle RL, Chertow GM, Zamanian RT.
J Card Fail.
2011;
17
(7):
533-9
-
Kidney function and long-term medication adherence after myocardial infarction in the elderly.
Chang TI,
Desai M, Solomon DH, Winkelmayer WC.
Clin J Am Soc Nephrol.
2011;
6
(4):
864-9
-
Posttransplantation anemia: mechanisms and management.
Yabu JM,
Winkelmayer WC.
Clin J Am Soc Nephrol.
2011;
6
(7):
1794-801
-
Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease care.
Winkelmayer WC,
Blood Purif.
2011;
31
(1-3):
66-9
-
The 2011 ESRD prospective payment system: an uncontrolled experiment.
Winkelmayer WC,
Chertow GM.
Am J Kidney Dis.
2011;
57
(4):
542-6
-
The effect of altitude change on anemia treatment response in hemodialysis patients.
Brookhart MA,
Bradbury BD, Avorn J, Schneeweiss S, Winkelmayer WC.
Am J Epidemiol.
2011;
173
(7):
768-77
-
The increasing prevalence of atrial fibrillation among hemodialysis patients.
Winkelmayer WC,
Patrick AR, Liu J, Brookhart MA, Setoguchi S.
J Am Soc Nephrol.
2011;
22
(2):
349-57
-
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.
Costenbader KH,
Desai A, Alarcón GS, Hiraki LT, Shaykevich T, Brookhart MA, Massarotti E, Lu B, Solomon DH, Winkelmayer WC.
Arthritis Rheum.
2011;
63
(6):
1681-8
-
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
Charytan DM,
Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, Winkelmayer WC.
Am J Kidney Dis.
2011;
58
(3):
409-17
-
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.
Devlin A,
Waikar SS, Solomon DH, Lu B, Shaykevich T, Alarcón GS, Winkelmayer WC, Costenbader KH.
Arthritis Care Res (Hoboken).
2011;
63
(12):
1642-53
-
What caused excess strokes in patients randomized to darbepoetin in the trial to reduce cardiovascular events with Aranesp therapy (TREAT)?: no smoking gun.
Winkelmayer WC,
Circulation.
2011;
124
(25):
2805-8
-
World Kidney Day 2011.
Hostetter TH,
Kochis DJ, Shaffer RN, Chertow G, Harmon WE, Klotman PE, Powe NR, Sedor JR, Smedberg PC, Watnick S, Winkelmayer WC.
J Am Soc Nephrol.
2011;
22
(3):
397-8
-
Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysis.
Winkelmayer WC,
Semin Dial.
2010 Sep-Oct;
23
(5):
486-91
-
ACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mellitus: are they underutilized?
Pappoe LS,
Winkelmayer WC.
Drugs Aging.
2010;
27
(2):
87-94
-
HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival.
Younas N,
Wu CM, Shapiro R, McCauley J, Johnston J, Tan H, Basu A, Schaefer H, Smetanka C, Winkelmayer WC, Unruh M.
BMC Nephrol.
2010:
11
5
-
Impact of reimbursement changes on statin use among patients with diabetes in Austria.
Winkelmayer WC,
Asslaber M, Bucsics A, Burkhardt T, Schautzer A, Wieninger P, Pogantsch M, Brookhart MA.
Wien Klin Wochenschr.
2010;
122
(3-4):
89-94
-
Kidney disease and antihypertensive medication adherence: the need for improved measurement tools.
Chang TI,
Winkelmayer WC.
Am J Kidney Dis.
2010;
56
(3):
423-6
-
Late referral to paediatric renal failure service impairs access to pre-emptive kidney transplantation in children.
Boehm M,
Winkelmayer WC, Arbeiter K, Mueller T, Aufricht C.
Arch Dis Child.
2010;
95
(8):
634-8
-
Medication issues in older individuals with CKD.
Rifkin DE,
Winkelmayer WC.
Adv Chronic Kidney Dis.
2010;
17
(4):
320-8
-
Off-label use of phosphate binders in non-dialysis-dependent CKD.
Winkelmayer WC,
Chertow GM.
Am J Kidney Dis.
2010;
56
(5):
813-6
-
On the relative safety of intravenous iron formulations: new answers, new questions.
Chertow GM,
Winkelmayer WC.
Am J Hematol.
2010;
85
(9):
643-4
-
Propensity scores in the presence of effect modification: A case study using the comparison of mortality on hemodialysis versus peritoneal dialysis.
Liem YS,
Wong JB, Hunink MM, de Charro FT, Winkelmayer WC.
Emerg Themes Epidemiol.
2010;
7
(1):
1
-
Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure.
Setoguchi S,
Choudhry NK, Levin R, Shrank WH, Winkelmayer WC.
Clin Pharmacol Ther.
2010;
88
(4):
548-54
-
The challenges of cost-effectiveness analyses for the clinician.
Erickson KF,
Winkelmayer WC.
Am J Kidney Dis.
2010;
56
(6):
1023-5
-
Chronic on acute renal failure: long-term implications of severe acute kidney injury.
Waikar SS,
Winkelmayer WC.
JAMA.
2009;
302
(11):
1227-9
-
Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials.
Kikić Z,
Lorenz M, Sunder-Plassmann G, Schillinger M, Regele H, Györi G, Mühlbacher F, Winkelmayer WC, Böhmig GA.
Transplantation.
2009;
88
(12):
1377-85
-
Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.
Bradbury BD,
Brookhart MA, Winkelmayer WC, Critchlow CW, Kilpatrick RD, Joffe MM, Feldman HI, Acquavella JF, Wang O, Rothman KJ.
Am J Kidney Dis.
2009;
54
(3):
554-60
-
Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.
Bradbury BD,
Do TP, Winkelmayer WC, Critchlow CW, Brookhart MA.
Pharmacoepidemiol Drug Saf.
2009;
18
(10):
932-40
-
Lessons from geographic variations in predialysis nephrology care.
Winkelmayer WC,
J Am Soc Nephrol.
2009;
20
(5):
930-2
-
Approaching the end of the homocysteine hype?
Sunder-Plassmann G,
Winkelmayer WC, Födinger M.
Am J Kidney Dis.
2008;
51
(4):
549-53
-
Associations of kidney function with cardiovascular medication use after myocardial infarction.
Winkelmayer WC,
Levin R, Setoguchi S.
Clin J Am Soc Nephrol.
2008;
3
(5):
1415-22
-
Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy.
Winkelmayer WC,
Setoguchi S, Levin R, Solomon DH.
Arch Intern Med.
2008;
168
(21):
2368-75
-
Educational level as a determinant of access to and outcomes after kidney transplantation in the United States.
Schaeffner ES,
Mehta J, Winkelmayer WC.
Am J Kidney Dis.
2008;
51
(5):
811-8
-
Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age.
Setoguchi S,
Solomon DH, Levin R, Winkelmayer WC.
Am J Cardiol.
2008;
101
(11):
1531-6
-
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
Setoguchi S,
Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC.
J Am Coll Cardiol.
2008;
51
(13):
1247-54
-
Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors.
Setoguchi S,
Levin R, Winkelmayer WC.
Int J Cardiol.
2008;
125
(2):
172-7
-
Medication adherence after myocardial infarction: a long way left to go.
Choudhry NK,
Winkelmayer WC.
J Gen Intern Med.
2008;
23
(2):
216-8
-
Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury.
Winkelmayer WC,
Waikar SS, Mogun H, Solomon DH.
Am J Med.
2008;
121
(12):
1092-8
-
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
Winkelmayer WC,
Tonelli M.
Am J Kidney Dis.
2008;
51
(3):
362-5
-
Pottransplantation anemia: management and rationale.
Winkelmayer WC,
Chandraker A.
Clin J Am Soc Nephrol.
2008:
3 Suppl 2
S49-55
-
The effect of altitude on dosing and response to erythropoietin in ESRD.
Brookhart MA,
Schneeweiss S, Avorn J, Bradbury BD, Rothman KJ, Fischer M, Mehta J, Winkelmayer WC.
J Am Soc Nephrol.
2008;
19
(7):
1389-95
-
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.
Choudhry NK,
Setoguchi S, Levin R, Winkelmayer WC, Shrank WH.
Pharmacoepidemiol Drug Saf.
2008;
17
(12):
1189-96
-
Use of recommended medications after myocardial infarction in Austria.
Winkelmayer WC,
Bucsics AE, Schautzer A, Wieninger P, Pogantsch M.
Eur J Epidemiol.
2008;
23
(2):
153-62
-
Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?
Fischer MA,
Choudhry NK, Winkelmayer WC.
Health Aff (Millwood).
2007 May-Jun;
26
(3):
800-7
-
A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients.
Winkelmayer WC,
Schaeffner ES, Chandraker A, Kramar R, Rumpold H, Sunder-Plassmann G, Födinger M.
Transpl Int.
2007;
20
(6):
505-11
-
Benzodiazepine use and mortality of incident dialysis patients in the United States.
Winkelmayer WC,
Mehta J, Wang PS.
Kidney Int.
2007;
72
(11):
1388-93
-
Cardiovascular risk and the thiazolidinediones: déjà vu all over again?
Solomon DH,
Winkelmayer WC.
JAMA.
2007;
298
(10):
1216-8
-
Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease.
Charytan DM,
Setoguchi S, Solomon DH, Avorn J, Winkelmayer WC.
Kidney Int.
2007;
71
(9):
938-45
-
Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands.
Liem YS,
Wong JB, Hunink MG, de Charro FT, Winkelmayer WC.
Kidney Int.
2007;
71
(2):
153-8
-
Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease.
Boehm M,
Riesenhuber A, Winkelmayer WC, Arbeiter K, Mueller T, Aufricht C.
Pediatr Nephrol.
2007;
22
(8):
1189-93
-
No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients.
Riegersperger M,
van Houte M, Födinger M, Wojcik J, Hörl WH, Winkelmayer WC, Sunder-Plassmann G.
Am J Nephrol.
2007;
27
(4):
390-6
-
Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
Fischer MA,
Morris CA, Winkelmayer WC, Avorn J.
Arch Intern Med.
2007;
167
(8):
840-6
-
Predialysis nephrologist care and access to kidney transplantation in the United States.
Winkelmayer WC,
Mehta J, Chandraker A, Owen WF, Avorn J.
Am J Transplant.
2007;
7
(4):
872-9
-
Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients.
Schaeffner ES,
Födinger M, Kramar R, Sunder-Plassmann G, Winkelmayer WC.
Transpl Int.
2007;
20
(3):
247-55
-
Renal dysfunction increases the risk of saphenous vein graft occlusion: results from the Post-CABG trial.
Wellenius GA,
Mukamal KJ, Winkelmayer WC, Mittleman MA.
Atherosclerosis.
2007;
193
(2):
414-20
-
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.
Choudhry NK,
Levin R, Winkelmayer WC.
Heart.
2007;
93
(8):
945-51
-
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis.
Patrick AR,
Winkelmayer WC, Avorn J, Fischer MA.
Pharmacoeconomics.
2007;
25
(11):
949-61
-
Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
Setoguchi S,
Glynn RJ, Avorn J, Levin R, Winkelmayer WC.
Am J Cardiol.
2007;
100
(7):
1061-7
-
Assessing health state utilities in elderly patients at cardiovascular risk.
Winkelmayer WC,
Benner JS, Glynn RJ, Schneeweiss S, Wang PS, Brookhart MA, Levin R, Jackson JD, Avorn J.
Med Decis Making.
2006 May-Jun;
26
(3):
247-54
-
Incidence of end-stage renal disease in patients with type 1 diabetes was 7.8% at 30 years after diagnosis.
Winkelmayer WC,
ACP J Club.
2006 Mar-Apr;
144
(2):
51
-
A prospective study of anaemia and long-term outcomes in kidney transplant recipients.
Winkelmayer WC,
Chandraker A, Alan Brookhart M, Kramar R, Sunder-Plassmann G.
Nephrol Dial Transplant.
2006;
21
(12):
3559-66
-
Angiotensin inhibition after myocardial infarction: does drug class matter?
Winkelmayer WC,
Fischer MA, Schneeweiss S, Levin R, Avorn J.
J Gen Intern Med.
2006;
21
(12):
1242-7
-
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G,
Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
J Am Soc Nephrol.
2006;
17
(3):
889-99
-
Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure.
Brenner L,
Singh AK, Campbell D, Frei F, Winkelmayer WC.
Clin J Am Soc Nephrol.
2006;
1
(3):
455-61
-
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation.
Wong W,
Agrawal N, Pascual M, Anderson DC, Hirsch HH, Fujimoto K, Cardarelli F, Winkelmayer WC, Cosimi AB, Tolkoff-Rubin N.
Transpl Int.
2006;
19
(8):
629-35
-
Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes.
Winkelmayer WC,
Zhang Z, Shahinfar S, Cooper ME, Avorn J, Brenner BM.
Diabetes Care.
2006;
29
(10):
2210-7
-
Endothelial progenitor cells in kidney transplant recipients.
Steiner S,
Winkelmayer WC, Kleinert J, Grisar J, Seidinger D, Kopp CW, Watschinger B, Minar E, Hörl WH, Födinger M, Sunder-Plassmann G.
Transplantation.
2006;
81
(4):
599-606
-
Genetic aspects of hyperhomocysteinemia in chronic kidney disease.
Sunder-Plassmann G,
Winkelmayer WC, Födinger M.
Semin Nephrol.
2006;
26
(1):
8-13
-
Kidney function and use of recommended medications after myocardial infarction in elderly patients.
Winkelmayer WC,
Charytan DM, Brookhart MA, Levin R, Solomon DH, Avorn J.
Clin J Am Soc Nephrol.
2006;
1
(4):
796-801
-
Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.
Winkelmayer WC,
Charytan DM, Levin R, Avorn J.
Am J Kidney Dis.
2006;
47
(2):
301-8
-
Predicting survival in patients requiring renal replacement therapy after cardiac surgery.
Leacche M,
Winkelmayer WC, Paul S, Lin J, Unic D, Rawn JD, Cohn LH, Byrne JG.
Ann Thorac Surg.
2006;
81
(4):
1385-92
-
Prognostic associations between lipid markers and outcomes in kidney transplant recipients.
Schaeffner ES,
Födinger M, Kramar R, Frei U, Hörl WH, Sunder-Plassmann G, Winkelmayer WC.
Am J Kidney Dis.
2006;
47
(3):
509-17
-
Surrogate markers in clinical studies: problems solved or created?
Manns B,
Owen WF, Winkelmayer WC, Devereaux PJ, Tonelli M.
Am J Kidney Dis.
2006;
48
(1):
159-66
-
The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic acute transplant failure and renal allograft survival.
Heinze G,
Collins S, Benedict MA, Nguyen LL, Kramar R, Winkelmayer WC, Haas M, Kainz A, Oberbauer R.
Transplantation.
2006;
82
(11):
1441-8
-
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.
Waikar SS,
Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, Sosa MA, Jaber BL.
J Am Soc Nephrol.
2006;
17
(6):
1688-94
-
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors.
Putnam KG,
Bohn RL, Ewenstein BM, Winkelmayer WC, Avorn J.
Haemophilia.
2005;
11
(3):
261-9
-
Anaemia after renal transplantation.
Lorenz M,
Winkelmayer WC, Hörl WH, Sunder-Plassmann G.
Eur J Clin Invest.
2005:
35 Suppl 3
89-94
-
Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients.
Winkelmayer WC,
Huber A, Wagner OF, Hörl WH, Sunder-Plassmann G, Födinger M.
Kidney Int.
2005;
67
(5):
1980-5
-
Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
Angus DC,
Linde-Zwirble WT, Tam SW, Ghali JK, Sabolinski ML, Villagra VG, Winkelmayer WC, Worcel M.
Circulation.
2005;
112
(24):
3745-53
-
Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients.
Winkelmayer WC,
Kramar R, Sunder-Plassmann G, Födinger M.
Kidney Int.
2005;
68
(6):
2857-62
-
Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.
Winkelmayer WC,
Kramar R, Curhan GC, Chandraker A, Endler G, Födinger M, Hörl WH, Sunder-Plassmann G.
J Am Soc Nephrol.
2005;
16
(1):
255-60
-
Habitual caffeine intake and the risk of hypertension in women.
Winkelmayer WC,
Stampfer MJ, Willett WC, Curhan GC.
JAMA.
2005;
294
(18):
2330-5
-
Identification of individuals with CKD from Medicare claims data: a validation study.
Winkelmayer WC,
Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH.
Am J Kidney Dis.
2005;
46
(2):
225-32
-
Long-term patient and graft survival in the eurotransplant senior program: a single-center experience.
Fabrizii V,
Kovarik J, Bodingbauer M, Kramar R, Hörl WH, Winkelmayer WC.
Transplantation.
2005;
80
(5):
582-9
-
The hepatotoxicity of antifungal medications in bone marrow transplant recipients.
Fischer MA,
Winkelmayer WC, Rubin RH, Avorn J.
Clin Infect Dis.
2005;
41
(3):
301-7
-
Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC,
Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J.
Am J Kidney Dis.
2005;
46
(6):
1080-7
-
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States.
Manns B,
Stevens L, Miskulin D, Owen WF, Winkelmayer WC, Tonelli M.
Kidney Int.
2004;
66
(3):
1239-47
-
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
Wong W,
Tolkoff-Rubin N, Delmonico FL, Cardarelli F, Saidman SL, Farrell ML, Shih V, Winkelmayer WC, Cosimi AB, Pascual M.
Clin Transplant.
2004;
18
(4):
341-8
-
C-reactive protein and body mass index independently predict mortality in kidney transplant recipients.
Winkelmayer WC,
Lorenz M, Kramar R, Födinger M, Hörl WH, Sunder-Plassmann G.
Am J Transplant.
2004;
4
(7):
1148-54
-
Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism.
Avorn J,
Winkelmayer WC.
Circulation.
2004;
110
(24 Suppl 1):
IV25-32
-
Effects of TCN2 776C>G on vitamin B, folate, and total homocysteine levels in kidney transplant patients.
Winkelmayer WC,
Skoupy S, Eberle C, Födinger M, Sunder-Plassmann G.
Kidney Int.
2004;
65
(5):
1877-81
-
How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions.
Wang PS,
Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J.
Pharmacoepidemiol Drug Saf.
2004;
13
(1):
11-9
-
Knowledge and attitude regarding organ donation among medical students and physicians.
Schaeffner ES,
Windisch W, Freidel K, Breitenfeldt K, Winkelmayer WC.
Transplantation.
2004;
77
(11):
1714-8
-
Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients.
Feix A,
Winkelmayer WC, Eberle C, Sunder-Plassmann G, Födinger M.
Atherosclerosis.
2004;
174
(1):
43-8
-
Patient and graft survival in older kidney transplant recipients: does age matter?
Fabrizii V,
Winkelmayer WC, Klauser R, Kletzmayr J, Säemann MD, Steininger R, Kramar R, Hörl WH, Kovarik J.
J Am Soc Nephrol.
2004;
15
(4):
1052-60
-
Patterns of co-occurrence of three single nucleotide polymorphisms of the 5,10-methylenetetrahydrofolate reductase gene in kidney transplant recipients.
Winkelmayer WC,
Sunder-Plassmann G, Huber A, Födinger M.
Eur J Clin Invest.
2004;
34
(9):
613-8
-
Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients.
Winkelmayer WC,
Lorenz M, Kramar R, Hörl WH, Sunder-Plassmann G.
Am J Transplant.
2004;
4
(12):
2075-81
-
Pharmacoepidemiology of anemia in kidney transplant recipients.
Winkelmayer WC,
Kewalramani R, Rutstein M, Gabardi S, Vonvisger T, Chandraker A.
J Am Soc Nephrol.
2004;
15
(5):
1347-52
-
Propensity scores: help or hype?
Winkelmayer WC,
Kurth T.
Nephrol Dial Transplant.
2004;
19
(7):
1671-3
-
Regarding impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis.
Tonelli M,
Owen WF, Jindal K, Winkelmayer WC, Manns B.
Kidney Int.
2004;
66
(4):
1712; author reply 1712-3
-
A propensity analysis of late versus early nephrologist referral and mortality on dialysis.
Winkelmayer WC,
Owen WF, Levin R, Avorn J.
J Am Soc Nephrol.
2003;
14
(2):
486-92
-
Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery.
Winkelmayer WC,
Levin R, Avorn J.
Am J Kidney Dis.
2003;
41
(1):
84-9
-
Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients.
Winkelmayer WC,
Eberle C, Sunder-Plassmann G, Födinger M.
Kidney Int.
2003;
63
(6):
2280-5
-
Hetastarch and bleeding complications after coronary artery surgery.
Avorn J,
Patel M, Levin R, Winkelmayer WC.
Chest.
2003;
124
(4):
1437-42
-
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery.
Winkelmayer WC,
Glynn RJ, Levin R, Avorn J.
Kidney Int.
2003;
64
(3):
1046-9
-
The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients.
Tonelli M,
Winkelmayer WC, Jindal KK, Owen WF, Manns BJ.
Kidney Int.
2003;
64
(1):
295-304
-
The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease.
Winkelmayer WC,
Levin R, Avorn J.
Kidney Int.
2003;
63
(5):
1836-42
-
Health economic evaluations: the special case of end-stage renal disease treatment.
Winkelmayer WC,
Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS.
Med Decis Making.
2002 Sep-Oct;
22
(5):
417-30
-
Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach.
Winkelmayer WC,
Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J.
J Am Soc Nephrol.
2002;
13
(9):
2353-62
-
Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure.
Avorn J,
Winkelmayer WC, Bohn RL, Levin R, Glynn RJ, Levy E, Owen W.
J Clin Epidemiol.
2002;
55
(7):
711-6
-
Late nephrologist referral and access to renal transplantation.
Winkelmayer WC,
Glynn RJ, Levin R, Mittleman MA, Pliskin JS, Avorn J.
Transplantation.
2002;
73
(12):
1918-23
-
Nephrologist care and mortality in patients with chronic renal insufficiency.
Avorn J,
Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn RJ.
Arch Intern Med.
2002;
162
(17):
2002-6
-
Preventive health care measures before and after start of renal replacement therapy.
Winkelmayer WC,
Owen W, Glynn RJ, Levin R, Avorn J.
J Gen Intern Med.
2002;
17
(8):
588-95
-
Determinants of delayed nephrologist referral in patients with chronic kidney disease.
Winkelmayer WC,
Glynn RJ, Levin R, Owen WF, Avorn J.
Am J Kidney Dis.
2001;
38
(6):
1178-84
-
Late referral and modality choice in end-stage renal disease.
Winkelmayer WC,
Glynn RJ, Levin R, Owen W, Avorn J.
Kidney Int.
2001;
60
(4):
1547-54
-
Optic neuropathy in uremia: an interdisciplinary emergency.
Winkelmayer WC,
Eigner M, Berger O, Grisold W, Leithner C.
Am J Kidney Dis.
2001;
37
(3):
E23
-
Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study.
Sunder-Plassmann G,
Födinger M, Buchmayer H, Papagiannopoulos M, Wojcik J, Kletzmayr J, Enzenberger B, Janata O, Winkelmayer WC, Paul G, Auinger M, Barnas U, Hörl WH.
J Am Soc Nephrol.
2000;
11
(6):
1106-16
-
Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.
Sunder-Plassmann G,
Winkelmayer WC, Födinger M.
Expert Opin Investig Drugs.
2000;
9
(11):
2637-51
Navigation for This Section: Nephrology
Find a Researcher
Help